Refractec Focuses On CK Astigmatism, Post-LASIK Treatment Indications
This article was originally published in The Gray Sheet
Refractec expects approval of a presbyopia indication for its CK Blended Vision radio wave procedure in early 2004, the company announced Sept. 30
You may also be interested in...
The National Alliance for Eye & Vision Research is proposing that the budget for the National Eye Institute increase roughly 12.3% to $711 mil. in fiscal 2004
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.